Infinium Pharmachem Limited (NSE:INFINIUM)

India · Delayed Price · Currency is INR

266.20

-7.80 (-2.85%)

Sep 11, 2026, 3:18 PM IST

Market Cap	4.15B +3.9%
Revenue (ttm)	1.90B +21.8%
Net Income	121.50M +49.2%
EPS	7.80 +39.2%
Shares Out	15.58M
PE Ratio	34.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,000
Open	260.00
Previous Close	274.00
Day's Range	257.00 - 270.00
52-Week Range	189.40 - 285.50
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Infinium Pharmachem

Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine based molecules/APIs/iodination reaction based bulk drugs. It also offers potassium iodide and iodate, sodium iodide, iodine, povidone iodine, pralidoxime iodid, and iodoform products. In addition, the company provides contract research and manufacturing services to pharmaceutical and biotech companies for iodine based APIs and intermediates. It se... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 2003

Employees 141

Stock Exchange National Stock Exchange of India

Ticker Symbol INFINIUM

Full Company Profile

Financial Performance

In fiscal year 2026, Infinium Pharmachem's revenue was 1.90 billion, an increase of 21.79% compared to the previous year's 1.56 billion. Earnings were 121.50 million, an increase of 49.17%.

Financial Statements